Clinical Trials on 腹膜肿瘤 in Korea, Republic of
总计7605个结果
-
Yonsei UniversityCanariaBio Inc.招聘中PARP 抑制剂耐药的卵巢癌、输卵管癌或原发性腹膜癌患者不适合铂类再治疗大韩民国
-
Korean Gynecologic Oncology Group未知
-
Gangnam Severance Hospital完全的
-
Samsung Medical Center未知
-
Seoul National University Hospital招聘中
-
Ajou University School of Medicine完全的
-
Seoul National University Bundang HospitalBoryung Pharmaceutical Co., Ltd; B. Braun Korea Co., Ltd.完全的
-
Seoul National University Bundang HospitalHospicare Co., Ltd.招聘中
-
Seoul National University HospitalFresenius Medical Care Korea完全的
-
Seoul National University Hospital完全的
-
Yonsei University完全的
-
The Catholic University of KoreaKorean Cancer Study Group完全的
-
Seoul National University HospitalPharos iBio Co., Ltd.招聘中
-
Kyungpook National University HospitalMinistry of Health & Welfare, Korea; Fresenius Medical Care Korea完全的
-
Seoul National University HospitalBoryung Pharmaceutical Co., Ltd主动,不招人
-
Seoul National University Hospital未知
-
Samsung Medical Center完全的
-
AstraZeneca完全的胃肿瘤 | 小细胞肺癌 | 卵巢肿瘤 | 输卵管肿瘤 | 腹膜肿瘤 | 三阴性乳腺肿瘤 | 食管鳞状细胞癌 | 癌,胰腺导管 | 癌,头颈部鳞状细胞 | 食管胃结合部肿瘤大韩民国, 日本
-
Samsung Medical Center招聘中
-
Seoul National University Bundang Hospital未知
-
Ewha Womans University Mokdong HospitalSeoul St. Mary's Hospital; Pusan National University Hospital; Chonnam National University Hospital 和其他合作者未知
-
Asan Medical Center完全的
-
Seoul National University Hospital完全的
-
The Catholic University of KoreaKyunghee University; Chonnam National University批准上市